Ariosa Diagnostics Appoints Dan Puckett as Chief Financial Officer and Dr. Thomas Musci as Chief Medical Officer

SAN JOSE, Calif., Nov. 7, 2013 /PRNewswire/ -- Ariosa Diagnostics, Inc., maker of the Harmony™ Prenatal Test, announced today that it has promoted Dan Puckett to Chief Financial Officer and Dr. Thomas Musci to Chief Medical Officer.

(Logo: http://photos.prnewswire.com/prnh/20130225/SF62999LOGO)

Dan Puckett joined Ariosa in September 2011 as Vice President of Finance and Administration.  He has been instrumental in developing the company's finance, accounting, purchasing, human resources, and facilities infrastructure.  His leadership has been vital to the company as it has rapidly transformed from a pre-commercial organization into the world's leading non-invasive prenatal testing (NIPT) provider.

Dr. Musci joined Ariosa in May 2012 as Vice President of Clinical and Medical Affairs and has successfully led the clinical development activities resulting in a significant number of peer-reviewed, published articles over the last 18 months. Additionally, he has cultivated a growing medical affairs department within Ariosa that provides genetic counseling and medical liaison expertise to Ariosa's clients throughout the world. His leadership on building key collaborations with top researchers in the field of prenatal medicine, as well as his engagement to build the global market footprint of the Harmony Test, have made him an invaluable addition to the Ariosa team.

Company CEO Dr. Ken Song said, "Tom and Dan have demonstrated strong leadership and commitment to Ariosa in providing the highest quality of service for the benefit of maternal and fetal health." 

About Ariosa Diagnostics

Ariosa Diagnostics, Inc. is a molecular diagnostics company committed to innovating together to improve patient care. The flagship product, the Harmony^™ Prenatal Test, is a safe, highly accurate and affordable prenatal test for maternal and fetal health. Led by an experienced team, Ariosa is using its proprietary technology to perform a directed analysis of cell-free DNA in blood. The Harmony^™ Prenatal Test equips pregnant women and their healthcare providers with reliable information to make decisions regarding their health, without creating unnecessary stress or anxiety.

The company began operations in 2010 and is headquartered in San Jose, Calif. For more information, visit www.ariosadx.com. Follow us on Twitter @HarmonyPrenatal and on Facebook at Harmony Prenatal for Healthy Pregnancy.

CONTACT: 
Jen Bruursema
408-229-7539
[email protected]

SOURCE Ariosa Diagnostics, Inc.